DCPH NASDAQ
Deciphera Pharmaceuticals, Inc.
1W: +0.1%
1M: +0.9%
3M: +59.0%
1Y: +82.5%
3Y: -24.4%
5Y: +18.7%
$25.59
Last traded 2024-06-11 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
📊 Key Metrics
TTM$175M
Revenue
+26.5% YoY
$-190M
Net Income
-7.9% YoY
$-152M
Free Cash Flow
+0.0% YoY
91.8%
Gross Margin
-108.6%
Op. Margin
-100.2%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-50.4%
ROA-39.3%
ROIC-238.0%
Valuation
P/E-11.2
P/B6.2
EV/EBITDA-5.8
Leverage
Debt/Equity0.08
Current Ratio4.19
Interest Cov.-54.4x
Quality Scores
Piotroski F2/9
Altman Z2.58
Beneish M-2.36